Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology
Aim. Evaluation of various methods for determining the effectiveness of aspirin therapy and aspirin resistance in patients with cerebrovascular disease (CVD) depending on the presence of type 2 diabetes mellitus (T2DM).Materials and methods. The prospective study included 78 patients with various ma...
Main Authors: | M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2534 |
Similar Items
-
Aspirin Therapy, Cognitive Impairment, and Dementia—A Review
by: Elizabeth H. Thong, et al.
Published: (2023-02-01) -
Aspirin resistance: clinical and molecular genetic evaluation techniques
by: M. M. Tanashyan, et al.
Published: (2017-02-01) -
Prevention of cerebrovascular disease in patients with myeloproliferatie disorders
by: Marine M. Tanashyan, et al.
Published: (2017-09-01) -
To continue or discontinue aspirin? The risk of perioperative complications
by: Anna Mroczek, et al.
Published: (2018-08-01) -
To continue or discontinue aspirin? The risk of perioperative complications
by: Anna Mroczek, et al.
Published: (2018-08-01)